COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

28,971 Articles (21,486 medRxiv, 7,485 bioRxiv)

Most recent first Previous |  Page 1668: Articles 16671-16680  | Next

A national survey of potential acceptance of COVID-19 vaccines in healthcare workers in Egypt
Mohamed-Hussein, A. A., sayed, i. g., Makhlouf, n., Makhlouf, H., Abd El Aal, H., Kholief, K., Saad, M. M., Abdellal, D. A.
10.1101/2021.01.11.21249324 — Posted: 2021-01-15
Physicians' Reactions to COVID-19: The Results of an International Internet Survey
Aneja, P., Singh, I., Singh, B., Kundi, P. S., Singh, I., Kathiravan, S., Singh, S. M.
10.1101/2021.01.13.21249460 — Posted: 2021-01-15
Impact of COVID-19 on Migrants' Access to Primary Care:A National Qualitative Study
Knights, F., Carter, J., Deal, A., Crawshaw, A. F., Hayward, S. E., Jones, L., Hargreaves, S.
10.1101/2021.01.12.21249692 — Posted: 2021-01-15
A mixture of essential oils from three Cretan Aromatic Plants (thyme, Greek sage and Cretan dittany, CAPeo) inhibits SASR-CoV-2 proliferation: in vitro evidence and a Proof-of-Concept intervention study in mild ambulatory COVID-19-positive patients
Lionis, C., Karakasiliotis, I., Petelos, E., Linardakis, M., Diamantakis, A., Symvoulakis, E., Panopoulou, M., Kampa, M., Pirintsos, S. A., Sourvinos, G., Castanas, E.
10.1101/2021.01.11.20248947 — Posted: 2021-01-15
Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain
Roel, E., Pistillo, A., Recalde, M., Sena, A. G., Fernandez-Bertolin, S., Aragon, M., Puente, D., Ahmed, W.-U.-R., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Blacketer, C., Carter, W., Casajust, P., Culhane, A. C., Dawoud, D., DeFalco, F., Duvall, S. L., Falconer, T., Golozar, A., Gong, M., Hester, L., Hripcsak, G., Tan, E. H., Jeon, H., Jonnagaddala, J., Lai, L. Y., Lynch, K. E., Matheny, M. E., Morales, D. R., Natarajan, K., Nyberg, F., Ostropolets, A., Posada, J. D., Prats-Uribe, A., Reich, C. G., Rivera, D., Schilling, L. M., Soerjomataram, I., Shah, K., Shah, N., Shen, Y., Spotnitz, M., Subbian, V., Suchard, M. A., Trama, A., Zhang, L., Zhang, Y., Ryan, P., Prieto-Alhambra, D., Kostka, K., Duarte-Salles, T.
10.1101/2021.01.12.21249672 — Posted: 2021-01-15
Mitigation of COVID-19 using social distancing of the elderly in Brazil: The vertical quarantine effects in hospitalizations and deaths
Ribeiro Venturieri, V., Silva Goncalves, M., Rios Fuck, V.
10.1101/2021.01.12.21249495 — Posted: 2021-01-15
Modelling the effect of lockdown
Kamei, H., Sato, A.
10.1101/2021.01.11.20248882 — Posted: 2021-01-15
Early immune pathology and persistent dysregulation characterise severe COVID-19
Bergamaschi, L., Mescia, F., Turner, L., Hanson, A., Kotagiri, P., Dunmore, B. J., Ruffieux, H., DeSa, A., Huhn, O., Wills, M. R., Baker, S., Doffinger, R., Dougan, G., Elmer, A., Goodfellow, I. G., Gupta, R. K., Hosmillo, M., Hunter, K., Kingston, N., Lehner, P. J., Matheson, N. J., Nicholson, J. K., Petrunkina, A. M., Richardson, S., Saunders, C., Thaventhiran, J. E. D., Toonen, E. J. M., Weekes, M. P., CambridgeInstituteofTherapeuticImmunologyandInfectiousDisease-NationalInstituteofHealthResearch(CITI, , Toshner, M., Hess, C., Bradley, J. R., Lyons, P. A., Smith, K. G. C.
10.1101/2021.01.11.20248765 — Posted: 2021-01-15 Discussion: Onsite
An optimised protocol for detection of SARS-COV-2 in stool
Li, T., Garcia-Gutierrez, E., Scadden, J., Davies, J., Hutchins, C., Aydin, A., Romano, S., Sayavedra, L., O'Grady, J., Narbad, A.
10.1101/2021.01.11.20248606 — Posted: 2021-01-15
Emergence of multiple SARS-CoV-2 mutations in an immunocompromised host
Khatamzas, E., Rehn, A., Muenchhoff, M., Hellmuth, J., Gaitzsch, E., Weiglein, T., Georgi, E., Scherer, C., Stecher, S., Weigert, O., Girl, P., Zange, S., Keppler, O. T., Stemmler, J., Bergwelt-Baildon, M., Woelfel, R., Antwerpen, M.
10.1101/2021.01.10.20248871 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).